KRW 1446.0
(-0.69%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 581.02 Million KRW | -32.91% |
2022 | 866.06 Million KRW | 88.18% |
2021 | 460.22 Million KRW | -89.48% |
2020 | 4.37 Billion KRW | 1995.85% |
2019 | 208.81 Million KRW | 506.47% |
2018 | 34.43 Million KRW | -78.55% |
2017 | 160.49 Million KRW | -40.65% |
2016 | 270.42 Million KRW | 44.51% |
2015 | 187.12 Million KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 617.74 Million KRW | 6.32% |
2024 Q2 | 515.44 Million KRW | -16.56% |
2023 Q2 | 895.59 Million KRW | -2.6% |
2023 Q1 | 919.48 Million KRW | 6.17% |
2023 FY | 581.02 Million KRW | -32.91% |
2023 Q4 | 581.02 Million KRW | -26.41% |
2023 Q3 | 789.56 Million KRW | -11.84% |
2022 FY | 866.06 Million KRW | 88.18% |
2022 Q4 | 866.06 Million KRW | 8.11% |
2022 Q3 | 801.09 Million KRW | 2.67% |
2022 Q2 | 780.29 Million KRW | 24.0% |
2022 Q1 | 629.26 Million KRW | 36.73% |
2021 Q2 | 3.73 Billion KRW | -14.98% |
2021 Q3 | 3.99 Billion KRW | 6.77% |
2021 FY | 460.22 Million KRW | -89.48% |
2021 Q4 | 460.22 Million KRW | -88.47% |
2021 Q1 | 4.39 Billion KRW | 0.47% |
2020 Q3 | 6.66 Billion KRW | 0.0% |
2020 FY | 4.37 Billion KRW | 1995.85% |
2020 Q1 | - KRW | -100.0% |
2020 Q4 | 4.37 Billion KRW | -34.36% |
2019 Q4 | 208.81 Million KRW | 0.0% |
2019 FY | 208.81 Million KRW | 506.47% |
2018 FY | 34.43 Million KRW | -78.55% |
2017 FY | 160.49 Million KRW | -40.65% |
2016 FY | 270.42 Million KRW | 44.51% |
2015 FY | 187.12 Million KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 15.04 Billion KRW | 96.139% |
InBody Co.,Ltd | 29.41 Billion KRW | 98.025% |
Curexo Inc. | 31.77 Billion KRW | 98.171% |
Seegene, Inc. | 137.63 Billion KRW | 99.578% |
i-SENS, Inc. | 83.54 Billion KRW | 99.305% |
Ray Co., Ltd. | 25.37 Billion KRW | 97.71% |
Sugentech Inc. | 7.01 Billion KRW | 91.723% |
L&C Bio Co., Ltd | 46.28 Billion KRW | 98.745% |